JDS1 – Concurrent Computer Corporation’s Largest

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
JDS1 – Concurrent Computer Corporation’s Largest Shareholder – Sends Open Letter to Chairman

FORT LEE, N.J., May 25, 2016 (GLOBE NEWSWIRE) -- JDS1 has sent the following letter to the Chairman of Concurrent Computer Corporation (NASDAQ: CCUR ), full text found below. 

May 24, 2016

Mr. Steve G. Nussrallah Chairman Concurrent Computer Corporation 4375 River Green Parkway, Suite 100 Duluth, GA 30096

Dear Mr. Nussrallah:

As my previous filings indicate, I am very concerned about the steps, or lack of steps, being taken by the Board of Directors of Concurrent Computer Corporation to exercise effective oversight and execute on Concurrent’s strategic plan to deliver to stockholders the value they deserve.  I was nevertheless wholly unprepared for the way I was treated during our conversation on May 4 th , the day after Concurrent’s most recent disappointing earnings announcement.  As you know, I had reached out to Mr. Elder, our CEO, that morning to discuss Concurrent’s continued poor financial performance.  When you returned my call, I was mildly troubled by your insistence that I speak only with you and not Mr. Elder.  I was considerably more troubled to find you so unwilling, or more likely, in my opinion, unable, to speak substantively to any of my concerns.  Your response to my question regarding our storage business—that I look to the new webpages—was shockingly disinterested.

It is unfortunate that we were not able to have a more meaningful conversation, and I was troubled that you did not appear to be interested in maintaining an open dialogue with your largest stockholder.  I approached our discussion with an open mind and with sincere hope that you would be able to address my concerns and answer the questions I intended to pose to Mr. Elder.  I came away more concerned than ever about the composition of the Board, its oversight of Concurrent’s business and its ability to deliver value to stockholders.

To date, I have done nothing but present my concerns as a stockholder, which, I believe, are concerns that are shared by a substantial portion of Concurrent stockholders.  I have been forthright in my offer to assist the Board and management in working together to correct Concurrent’s strategic direction and chronic underperformance.  As the holder of 9.4% of Concurrent’s outstanding shares, I believe that stockholders should be appropriately represented on the Board.  Regrettably, four members of the current Board have been directors since at least 2005 and together beneficially owned, as disclosed in last year’s proxy statement, only approximately 1.6% of the outstanding shares, including their unexercised stock options that reflect no out-of-pocket investment in Concurrent.

Mr. Nusrallah, your Chairmanship has presided over the decrease in Concurrent’s stock price from above $176 per share to, as of the close on May 20, 2016, $5.80 per share, an approximately 97% decline and a destruction of greater than $9 billion dollars in stockholder value.  What recent increase there has been in Concurrent’s stock price—which you pointed to as a reason not to pursue stockholder representation on the Board—tracks closely with the regulatory disclosure of my current position and intent, and with Concurrent’s beginning, grudgingly, to take some of the steps I have recommended from the outset, such as selling underperforming assets and returning capital to stockholders.  If anything, the recent increase in Concurrent’s stock price indicates that the market favors my input and advice.  Resorting to name-calling and personal attacks, in the face of genuine attempts by your largest stockholder to help unlock the significant value that the Board has let languish for over a decade, is unacceptable.  Asking stockholders to continue to wait as leadership continues to destroy value is not an option.

Over the past several months, I have attempted to communicate directly with management and the Board in an effort to work together constructively towards what should be our shared goal: creating value for Concurrent stockholders.  I have repeatedly reiterated my interest in avoiding a drawn-out proxy contest, and in working constructively with you and other directors to realize the full value of Concurrent’s assets.  Instead of acknowledging these efforts, your response has confirmed my perception of an insular culture and a narrow-minded, long-tenured Board.  Your behavior has been concerning, to say the least, and indicates a disconcerting unwillingness to seriously consider my input as Concurrent’s largest stockholder and, I believe, as a representative voice for the concerns of Concurrent stockholders at large.

There is an unfortunate and significant track record in the form of Concurrent’s long and painful decline in stock price from the beginning of your tenure in 2000 to now.  This record leaves little to suggest to stockholders that maintaining the status quo is a prudent course.  I strongly believe that Concurrent will not be able to unlock the significant value of its business as long as the Board continues to remain substantially occupied by entrenched, long-tenured directors who do not have a significant equity interest in Concurrent.  Avoiding a costly and protracted proxy contest by appointing myself and Mr. Stecker—as we had offered—to the Board in place of two of the long-tenured directors would send a clear message to stockholders and to the marketplace that the Board understands the need to make changes that will preserve and enhance Concurrent’s value with a sense of urgency that has thus far been lacking.

It is not too late to do the right thing.  In light of such self-evident problems as Concurrent faces, the Board has an obligation to take decisive action and illustrate to stockholders its commitment to change.  I urge you to confirm the Board’s commitment to sound business judgment by taking actions that will create an appropriate alignment between those with a significant financial interest in Concurrent’s future and the representatives responsible for the decisions that most affect that future.

JDS1, LLC
 
/s/ Julian Singer
By:  Julian Singer
Title:  Manager

cc:           Board of Directors, Concurrent Computer Corporation                 Derek Elder, Concurrent Computer Corporation

Additional Information and Where to Find It JDS1, LLC (“ JDS1 ”), Julian Singer and the other participants, if any, to be named therein (the “ Participants ”) intend to file a preliminary proxy statement (the “ Proxy Statement ”) with the Securities and Exchange Commission (the “ SEC ”) in connection with the solicitation of proxies for the 2016 Annual Meeting of Stockholders or any special meeting held in lieu thereof to elect directors (the “ Annual Meeting ”) of Concurrent Computer Corporation (the “ Company ”).  As of the date hereof, JDS1 (and Julian Singer, as managing member of JDS1) beneficially owns 894,536 shares of the Company’s common stock.  Additional information regarding the interests of the Participants will be included in the Proxy Statement and other relevant documents to be filed with the SEC in connection with the Annual Meeting. STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS ARE FILED WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Stockholders may obtain, free of charge, copies of the definitive Proxy Statement and any other relevant documents filed by the Participants with the SEC in connection with the Annual Meeting at the SEC’s web site ( http://www.sec.gov ). In addition, the Participants will provide copies of the Proxy Statement without charge, when available, upon request.  Requests for copies should be directed to the Participants’ proxy solicitor.

For Inquiries please contact: Kingsdale Shareholder Services Sylvia Hermina 646-651-1642 shermina@kingsdaleshareholder.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 138

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 203

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 197

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 159

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
IEHP's Wellness Center Launch Faces Delay in California

Updated Category News Views 104

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Continue Reading
Dana Concludes Tender Offers for Senior Notes

Updated Category News Views 151

An Investor's Glance at Dana's Strategic Moves Dana Incorporated (NYSE: DAN) just pulled a bold move with their tender offers, snapping up a hefty $357,873,000 in outstanding principal on their senior notes. This isn’t just pocket change; folks holding out for securities can feel the tension of watching big numbers get shuffled around. You gotta wonder, what's the play...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 267

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 288

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 150

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading

Top 5 Most Recently Viewed Articles

Join the Semtech Corporation Class Action for Investor Rights

Updated Category News Views 187

Understand the Semtech Corporation Class Action Lawsuit Investors in Semtech Corporation, a well-known player in the semiconductor industry, are now being notified of a class action lawsuit. This legal matter aims to seek justice for those adversely affected by alleged securities fraud. The law firm Levi & Korsinsky, LLP is leading this initiative, reaching out to...

Continue Reading
Gary P. Gilroy Receives Prestigious Music Award in 2025

Updated Category News Views 155

Celebrating a Music Education Legend In an exciting development for music education, Gary P. Gilroy, a distinguished Professor of Music Emeritus and Director of Bands Emeritus at California State University, Fresno, has been recognized for his outstanding contributions in this field. He was recently awarded the prestigious George N. Parks Award for Leadership in Music...

Continue Reading
Tech CEO Advocates for Honest Conversations on AI Job Impact

Updated Category News Views 159

Embracing AI Transparency in the Workplace As technology continues to progress rapidly, it's crucial for leaders to prioritize clear communication about how artificial intelligence is affecting the job market. Recently, Jim Kavanaugh, the CEO of World Wide Technology, highlighted that employees are smart enough to see through any misleading narratives surrounding AI's...

Continue Reading
Innocan Pharma Expands Patent Reach in Asian Markets for CBD

Updated Category News Views 175

Innocan Pharma's Expansion in Asian Markets Innocan Pharma Corporation, a key player in the pharmaceutical and biotechnology arenas, has taken significant strides in its efforts to expand its intellectual property coverage for its innovative liposomal CBD injection. This strategic development focuses on the expansive Asian pharmaceutical market, particularly highlighting...

Continue Reading
CYFOX Unveils Innovative Email Security for Microsoft 365

Updated Category News Views 281

CYFOX Introduces Groundbreaking Email Security Solution CYFOX, a forward-thinking cybersecurity company, has recently launched an advanced email security solution that integrates seamlessly with Microsoft 365. This innovative framework eliminates the hassle of MX record adjustments and domain-level alterations, making it easier for organizations to enhance their email...

Continue Reading